201 related articles for article (PubMed ID: 6803562)
1. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
Wenting GJ; de Bruyn JH; Man in't Veld AJ; Woittiez AJ; Derkx FH; Schalekamp MA
Am J Cardiol; 1982 Apr; 49(6):1453-9. PubMed ID: 6803562
[No Abstract] [Full Text] [Related]
2. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
[No Abstract] [Full Text] [Related]
3. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
[No Abstract] [Full Text] [Related]
4. Long-term efficacy of captopril in renovascular and essential hypertension.
Case DB; Atlas SA; Marion RM; Laragh JH
Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
[TBL] [Abstract][Full Text] [Related]
5. Active and inactive renin after a single dose of captopril in hypertensive patients.
Glorioso N; Dessi Fulgheri P; Madeddu P; Fois G; Palermo M; Cocco F; Dettori S; Rappelli A
Am J Cardiol; 1982 Apr; 49(6):1552-4. PubMed ID: 7041596
[TBL] [Abstract][Full Text] [Related]
6. [Captopril in renal artery stenoses and renal insufficiency].
Kirchertz EJ; Scheler F
Internist (Berl); 1982 Apr; 23(4):237-40. PubMed ID: 7045027
[No Abstract] [Full Text] [Related]
7. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome.
Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI; Davies DL
Am J Cardiol; 1982 Apr; 49(6):1460-6. PubMed ID: 7041585
[TBL] [Abstract][Full Text] [Related]
8. [Captopril in the clinical treatment of renovascular hypertension].
Ribeiro AB; Alves Filho G; de Almeida FA; Kohlmann Junior O; Stella SR; Ramos OL
AMB Rev Assoc Med Bras; 1980 May; 26(5):153-6. PubMed ID: 7005991
[No Abstract] [Full Text] [Related]
9. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392
[No Abstract] [Full Text] [Related]
10. Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state.
de Bruyn JH; Wenting GJ; Man in 'T Veld AJ; Derkx FH; Schalekamp MA
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():83s-86s. PubMed ID: 7004742
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
[No Abstract] [Full Text] [Related]
12. Increase in plasma aldosterone during prolonged captopril treatment.
Lijnen P; Staessen J; Fagard R; Amery A
Am J Cardiol; 1982 Apr; 49(6):1561-3. PubMed ID: 7041598
[TBL] [Abstract][Full Text] [Related]
13. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Weber MA; Drayer JI; Priest RT; Chen TC
Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
[TBL] [Abstract][Full Text] [Related]
14. Effect of captopril on renal hemodynamics in the treatment of resistant renal hypertension.
Björck S; Herlitz H; Nyberg G; Granerus G; Aurell M
Hypertension; 1983; 5(5 Pt 2):III152-3. PubMed ID: 6354931
[TBL] [Abstract][Full Text] [Related]
15. [Captopril - profile of a new antihypertensive (author's transl)].
Gross F
MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
[TBL] [Abstract][Full Text] [Related]
16. Captopril in the treatment of clinical hypertension and cardiac failure.
Atkinson AB; Robertson JI
Lancet; 1979 Oct; 2(8147):836-9. PubMed ID: 90928
[No Abstract] [Full Text] [Related]
17. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension.
Imai Y; Abe K; Otsuka Y; Sakurai Y; Ito T; Sato M; Haruyama T; Omata K; Hiwatari M; Yoshinaga K
Jpn Heart J; 1980 Nov; 21(6):793-802. PubMed ID: 7007685
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
[TBL] [Abstract][Full Text] [Related]
19. [Use of captopril in arterial hypertension with a stable and malignant course].
Lordkipanidze NL
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
[No Abstract] [Full Text] [Related]
20. Captopril in treatment-resistant essential and renal hypertension.
Aurell M; Delin K; Herlitz H
Scand J Urol Nephrol; 1982; 16(3):243-9. PubMed ID: 6761860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]